Teleflex Incorporated Receivables Turnover Ratio (TFX), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Teleflex Incorporated  (NYSE: TFX)
 

Teleflex Incorporated Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Teleflex Incorporated's ability to collect accounts receivable sequentially worsen to 3.9, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Teleflex Incorporated's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 94 days, from 90 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 418 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 2391 to 2763.

What is Receivable Turnover Ratio?
What is Teleflex Incorporated Selling?


What is Receivable Turnover Ratio?





TFX Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 28 2025)
III. Quarter
(Jun 29 2025)
II. Quarter
Y / Y Receivable Change -29.04 % -21.31 % 52.42 % 26.03 % 14.46 %
Y / Y Revenue Change -26.89 % -21.85 % - 19.43 % 4.09 %
Receivable Turnover Ratio (TTM) 3.9 4.05 4.16 7.1 7.26
TFX's Total Ranking # 2763 # 2391 # 2232 # 2081 # 2003
Accounts Receivable average collection period days 93 90 88 51 50
Seq. Receivable Change -0.25 % 5.77 % -41.69 % 15.34 % 10.61 %
Seq. Revenue Change 4.18 % - - 16.99 % 11.37 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 158
Healthcare Sector # 419
Overall Market # 2763

Receivable Turnover Ratio Statistics
High Average Low
0.47 0.41 0.23
(Dec 31 2016)   (Jun 30 2026)






Financial Statements
Teleflex Incorporated's Accounts Receivable $ 365 Millions Visit TFX's Balance sheet
Teleflex Incorporated's Sales TTM $ 1,629 Millions Visit TFX's Income Statement
Sources of TFX's Revenues Visit TFX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TFX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TFX's Growth Rates TFX's Roa TFX's Inventory Turnover Ratio TFX's Dividend Comparisons
TFX's Profitability Ratios TFX's Roi TFX's Asset Turnover Ratio TFX's Dividend Growth
TFX's Valuation Ratios TFX's Roe TFX's Financial Strength Ratios TFX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.98 $ 8.855  Millions$ 0.739  Millions
Teladoc Health Inc   11.88 $ 2,489.480  Millions$ 209.556  Millions
Premier Air Charter Holdings Inc   11.72 $ 31.562  Millions$ 2.692  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Icu Medical Inc  11.42 $ 2,159.998  Millions$ 189.166  Millions
National Healthcare Corp  11.40 $ 1,559.020  Millions$ 136.723  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Vaso Corporation  11.31 $ 80.220  Millions$ 7.094  Millions
Innoviva Inc   11.22 $ 420.630  Millions$ 37.491  Millions
Lifeloc Technologies Inc   11.19 $ 9.269  Millions$ 0.828  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Caredx Inc   10.81 $ 458.089  Millions$ 42.359  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Radnet Inc   10.53 $ 2,268.932  Millions$ 215.450  Millions
Kymera Therapeutics Inc   10.50 $ 105.000  Millions$ 10.000  Millions
Irhythm Holdings Inc   10.42 $ 825.702  Millions$ 79.250  Millions
Integrated Biopharma Inc  10.38 $ 42.568  Millions$ 4.101  Millions
Viemed Healthcare Inc   10.36 $ 301.606  Millions$ 29.102  Millions
Lensar Inc   10.33 $ 60.264  Millions$ 5.836  Millions
Immucell Corporation  10.30 $ 29.777  Millions$ 2.891  Millions
Addus Homecare Corp  10.25 $ 1,475.610  Millions$ 143.923  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Biodesix Inc   10.21 $ 102.939  Millions$ 10.081  Millions
Kestra Medical Technologies Ltd   10.00 $ 105.939  Millions$ 10.590  Millions
United Therapeutics Corporation  9.93 $ 3,154.500  Millions$ 317.550  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions

Date modified: 2026-09-08T15:11:45+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.